Ghosh, S.

patient mucosal healing bowel healing mucosal bowel preservation disease treatment fliximab preservation ni -0401 therapy study crohn -0401 remission group expert panel consensus response trial panel expert number surgery survey table placebo level endoscopic score antibody hospitalization round flammation factor delphi t cells certolizumab pegol tnf antagonists volume endoscopy baseline abbott result modulation flammatory bowel disease fication antagonist tcr-cd 3 cytokine cytokine release placebo group t-cell steering committee effect anti-cd meeting population netherland certolizumab safety topic gastroenterology disease course infusion bowel function randomized fliximab treatment adalimumab cd 3 modulation week 6 fi rst patient quanti fication course 10 mg pegol outcome centocor complication